2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 1 - 6 of 6 drug pricing articles
Sort by:
Newest Most Popular
How Much Does Keytruda Cost with Insurance in the U.S.? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost with Insurance in the U.S.?

• 188 views

In 2026, most patients pay between $300 and $3,000 per month depending on their plan, deductible, and location. This complete guide breaks down Keytruda prices with and without insurance, Medicare coverage, patient assistance programs, and expert insights to help Americans save on cancer treatment costs.

How Much Does Keytruda Cost in the US in 2025? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost in the US in 2025?

• 443 views

How Much Does Keytruda Cost in the US in 2025? Price per Dose, Monthly Cost, and Insurance Coverage Updated: October 1, 2025 Keytruda (pembrolizumab) remains one of the most prescribed immunotherapy treatments for cancers such as melanoma, non-small cell lung cancer, and head and neck cancers. But for patients and families, the most pressing question is often: “How much does Keytruda cost in the US in 2025?” In this guide, we break down the latest Keytruda prices per dose, monthly treatment costs, and annual expenses. We also compare prices from leading sources like GoodRx , Drugs.com , and SingleCare to help you understand the current landscape. Beyond raw prices, we explain how insurance coverage, Medicare, and manufacturer assistance programs can dramatically reduce out-of-pocket costs. If you or a loved one are exploring treatment with Keytruda, this resource provides the most up-to-date 2025 information to help you plan financially and discuss options with your healthcare provider.

Imfinzi Cost in the USA 2025: Price, Treatment for Lung Cancer, and Insurance Coverage - 2026 Drug Cost Analysis

Imfinzi Cost in the USA 2025: Price, Treatment for Lung Cancer, and Insurance Coverage

• 319 views

Imfinzi Cost in the USA 2025: What Patients Need to Know Imfinzi (durvalumab) has become a vital immunotherapy option for patients with lung cancer in the United States, but its price remains a major concern in 2025. The average cost of a single Imfinzi infusion is estimated at $10,000–$12,000, which means that annual treatment expenses can easily exceed $140,000 per year before insurance or assistance programs are applied. For patients and caregivers, understanding the true cost of Imfinzi involves more than just the drug’s wholesale price. Factors such as insurance coverage, Medicare Part B rules, infusion center administration fees, and manufacturer co-pay assistance all play a role in determining what you will actually pay out-of-pocket. The good news is that programs like AstraZeneca Access 360 and patient savings support can dramatically lower costs, sometimes reducing co-pays to as little as $0 for eligible patients. In this updated 2025 guide, we provide detailed price breakdowns, comparisons with other immunotherapies like Keytruda and Opdivo, insurance coverage insights, and 20 frequently asked questions (FAQs) to help you navigate Imfinzi’s financial impact.

Keytruda Cost in 2025: Real Monthly Price, Insurance Coverage & Patient Tips - 2026 Drug Cost Analysis

Keytruda Cost in 2025: Real Monthly Price, Insurance Coverage & Patient Tips

• 283 views

Keytruda (pembrolizumab) is one of the most widely prescribed immunotherapy drugs for cancer — but its high cost often leaves patients wondering how much they will actually pay. In 2025, the average list price for a single Keytruda infusion is around $11,000–$12,000, with annual costs exceeding $190,000 before insurance. Fortunately, Medicare, Medicaid, and private insurers cover most of these expenses, and copay assistance programs can reduce patient costs to as little as $25 per infusion. This guide explains the real monthly price of Keytruda in 2025, how insurance coverage works, and practical tips patients can use to lower out-of-pocket expenses.

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025? - 2026 Drug Cost Analysis

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025?

• 382 views

In 2025, the cost of Opdivo (Nivolumab) in the United States continues to be a major concern for cancer patients and families. With monthly expenses ranging from $12,000 to $26,000 without insurance, many wonder how they can afford this life-saving immunotherapy. This article explains the true price of Opdivo in 2025, how much insurance covers, available patient assistance programs, and how Opdivo compares to other cancer treatments like Keytruda and Yervoy. You’ll also find updated FAQs with trusted links to help patients make informed financial and medical decisions.

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025 - 2026 Drug Cost Analysis

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025

• 516 views

In 2025, the cost of Opdivo (nivolumab) in the United States remains a major concern for cancer patients and caregivers. With list prices starting at around $7,600 per infusion and reaching over $36,000 per vial, understanding insurance coverage, financial assistance programs, and the newly approved subcutaneous form (Opdivo Qvantig) is essential. This guide explains the latest prices, cost-saving options, and answers the most common questions about Opdivo treatment in the U.S.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings
2026 UPDATE
💊
2026 Drug Cost Guide
Keytruda • Wegovy • Mounjaro • Zepbound
Insurance Coverage Savings Tips Price Trends
Get Free Guide →
💰
Drug Cost Calculator
Compare Prices & Save Money
Average Savings: 65%
Trending Drug Prices 2026
🩺
Keytruda
$12,500/month
+5.2%
⚖️
Wegovy
$1,349/month
-2.1%
📊
Mounjaro
$1,023/month
+3.8%
💉
Zepbound
$1,059/month
NEW
View All Drug Prices & Insurance Info
Medical Categories
All Articles 6 Advanced Cancer Stage Treatment Cost Breakdown 9 Cancer Treatment & Specialized Care 11 Cancer Treatment Cost & Financial Assistance 14 Cardiology & Heart Surgery 1 Dental Treatments 0 Dermatology & Skin Treatments 0 Eye Surgery 0 Fertility & IVF 0 Hair Transplant 3 Health Insurance Premiums & Oncology Coverage 16 Immunotherapy & Personalized Cancer Therapy Pricing 11 Oncology Drug Costs & Insurance 26 Orthopedic Surgery 0 Plastic & Cosmetic Surgery 0 Weight Loss Drug Costs & Insurance Coverage 11 Weight Loss Surgery 4
Most Viewed
Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025?
Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025?
1334 views
Keytruda Price Per Dose vs. Per Year — Full Breakdown (2025)
Keytruda Price Per Dose vs. Per Year — Full Breakdown (2025)
722 views
How Much Does Keytruda Cost Per Month?
How Much Does Keytruda Cost Per Month?
692 views